Abeona Therapeutics Inc.（ABEO）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · ABEO · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-12	2024-12	2023-12	2022-12	2021-12
Revenue
Revenue	$5.82M	$0.00M	$3.50M	$1.41M	$3.00M
Cost of Revenue	$1.53M	$2.91M	$1.60M	$0.45M	$0.00M
Gross Profit	$4.29M	($2.91M)	$1.90M	$0.96M	$3.00M
Gross Margin %(computed)	73.68%	—	54.14%	68.18%	100.00%
Operating Expenses
R&D Expenses	$26.81M	$34.36M	$31.09M	$28.96M	$38.73M
G&A Expenses	$65.03M	$29.85M	$19.00M	$17.26M	$21.64M
Total Operating Expenses	$93.74M	$61.30M	$49.03M	$51.88M	$92.84M
Operating Income	($89.45M)	($64.21M)	($47.13M)	($50.91M)	($89.84M)
Operating Margin %(computed)	—	—	—	—	—
Interest Income	$5.56M	$4.25M	$2.12M	$0.43M	$0.04M
Interest Expense	$3.74M	$4.21M	$0.42M	$0.74M	$3.66M
Income Before Tax	$71.28M	($63.73M)	($54.19M)	($39.70M)	($84.94M)
Income Tax Expense	$0.10M	$0.00M	$0.00M	$0.00M	$0.00M
Net Income	$71.18M	($63.73M)	($54.19M)	($39.70M)	($84.94M)
Net Margin %(computed)	—	—	—	—	—
Per Share & EBITDA
EPS (Basic)	$1.34	$-1.55	$-2.53	$-5.53	$-21.50
Wtd Avg Shares	52.95M	41.05M	21.38M	7.86M	3.94M
EBITDA	($85.89M)	($56.62M)	($50.57M)	($34.38M)	($76.82M)
EBITDA Margin %(computed)	—	—	—	—	—